Effect of colchicine after primary acute coronary syndrome in heart failure with preserved ejection fraction

11 May 2026 (11:04 - 12:21)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Hamlet Hayrapetyan

Erebouni Medical Center, Yerevan (Armenia)

6 More presentations in this session

Presentation thumbnail

Finerenone in everyday heart failure care

Doctor G. Mihelcic (London, GB)

Abstract Slides

Presentation thumbnail

Long-term maintenance of guideline-directed medical therapy and its prognostic impact in a community-based heart failure unit

Doctor M. Ferre-Vallverdu (Reus, ES)

Abstract Slides

Presentation thumbnail

Prognostic effect of rapid-up titration programme of guideline-directed medical therapy in heart failure: real-world experience from a multicentre observational study

Doctor Z. Forrai (Budapest, HU)

Abstract Slides

Presentation thumbnail

The applicability of vericiguat therapy in a real-world cohort of hospitalised patients with heart failure with reduced ejection fraction

Doctor Z. Forrai (Budapest, HU)

Abstract Slides

Presentation thumbnail

Impacts of a rapid up-titration programme of guideline-directed medical therapy on quality of life: patient-reported outcomes from a multicentre heart failure study

Doctor M. Kovacs (Debrecen, HU)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy (6)

The Event

Event poster

Heart Failure 2026

11 May 2026 11:04 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources